Two-year changes in lipids and lipoproteins associated with the maintenance of a 5% to 10% reduction in initial weight: some findings and some questions
- PMID: 10102254
- DOI: 10.1002/j.1550-8528.1999.tb00699.x
Two-year changes in lipids and lipoproteins associated with the maintenance of a 5% to 10% reduction in initial weight: some findings and some questions
Abstract
Objective: This study assessed whether a 5% to 10% reduction in initial weight would be associated with as favorable long-term (i.e., 100 weeks) changes in lipids and lipoproteins, as have been observed on a short-term basis (i.e., 8 weeks).
Research methods and procedures: This was a prospective evaluation of 25 obese women, each of whom had lost > or =5% of initial weight during 48 weeks of treatment and had maintained a weight loss of this magnitude at 1-year follow-up (week 100). Lipids and lipoproteins were obtained at baseline and at weeks 8, 24, 48, and 100. All participants had a baseline total cholesterol > or =5.17 mmol/L (200 mg/dL).
Results: At the end of the first 8 weeks, weight fell an average of 11.7+/-2.8%, total cholesterol 20.6+/-7.5%, low-density-lipoprotein (LDL) cholesterol 23.0+/-18.1%, and triglycerides 26.0+/-20.1%. At week 48, weight had fallen to 20.1+/-7.0% below baseline, but total cholesterol and LDL cholesterol were reduced only 11.5+/-10.4% and 12.0+/-14.0% below baseline, respectively. These latter reductions were significantly (p<0.05) smaller than those observed at week 8, despite the larger weight loss at week 48. High-density-lipoprotein cholesterol declined significantly (p<0.05) during the first 8 weeks, but returned to baseline values by week 24. Patients gained 7.4+/-7.4 kg from weeks 48 to 100, during which time total and LDL cholesterol (but not triglycerides) rose significantly (p<0.05). Patients who, at week 100, maintained losses >10% of initial weight had significantly greater reductions in total and LDL cholesterol values than did patients who maintained losses of only 5% to 10% of initial weight.
Discussion: Results of this study underscore the importance of assessing long-term changes in weight-related health complications when patients have lost weight but are no longer dieting (and exercising) as aggressively as they did during the initial months of treatment.
Comment in
-
The importance of timing and accurate interpretation of the benefits of weight reduction on plasma lipids.Obes Res. 1999 Mar;7(2):227-8. doi: 10.1002/j.1550-8528.1999.tb00706.x. Obes Res. 1999. PMID: 10102261 Review. No abstract available.
Similar articles
-
Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise.N Engl J Med. 1988 Nov 3;319(18):1173-9. doi: 10.1056/NEJM198811033191801. N Engl J Med. 1988. PMID: 3173455 Clinical Trial.
-
Relation of weight loss to changes in serum lipids and lipoproteins in obese women.Am J Clin Nutr. 1995 Aug;62(2):350-7. doi: 10.1093/ajcn/62.2.350. Am J Clin Nutr. 1995. PMID: 7625342 Clinical Trial.
-
Long-term weight control study. VII (weeks 0 to 210). Serum lipid changes.Clin Pharmacol Ther. 1992 May;51(5):634-41. doi: 10.1038/clpt.1992.75. Clin Pharmacol Ther. 1992. PMID: 1587078 Clinical Trial.
-
Effects of weight loss in overweight/obese individuals and long-term lipid outcomes--a systematic review.Obes Rev. 2004 Feb;5(1):43-50. doi: 10.1111/j.1467-789x.2004.00127.x. Obes Rev. 2004. PMID: 14969506 Review.
-
Life-style and serum lipids and lipoproteins.J Atheroscler Thromb. 2000;7(4):177-97. doi: 10.5551/jat1994.7.177. J Atheroscler Thromb. 2000. PMID: 11521681 Review.
Cited by
-
Obesity and risk for its comorbidities diabetes, hypertension, and dyslipidemia in Japanese individuals aged 65 years.Sci Rep. 2023 Feb 9;13(1):2346. doi: 10.1038/s41598-023-29276-7. Sci Rep. 2023. PMID: 36759688 Free PMC article.
-
Effect of behavioral weight-loss program on biomarkers of cardiometabolic disease risk: Heart Health Study randomized trial.Obesity (Silver Spring). 2023 Feb;31(2):338-349. doi: 10.1002/oby.23618. Epub 2023 Jan 9. Obesity (Silver Spring). 2023. PMID: 36621902 Free PMC article. Clinical Trial.
-
Management of Dyslipidemia in Endocrine Diseases.Endocrinol Metab Clin North Am. 2022 Sep;51(3):589-602. doi: 10.1016/j.ecl.2022.02.003. Epub 2022 Jul 6. Endocrinol Metab Clin North Am. 2022. PMID: 35963630 Free PMC article. Review.
-
Impact of starting BMI and degree of weight loss on changes in appetite-regulating hormones during diet-induced weight loss.Obesity (Silver Spring). 2022 Apr;30(4):911-919. doi: 10.1002/oby.23404. Epub 2022 Mar 6. Obesity (Silver Spring). 2022. PMID: 35253406 Free PMC article.
-
Body weight variability is not associated with changes in risk factors for cardiometabolic disease.Int J Cardiol Hypertens. 2020 Aug 2;6:100045. doi: 10.1016/j.ijchy.2020.100045. eCollection 2020 Sep. Int J Cardiol Hypertens. 2020. PMID: 33447771 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical